J7295 Insurance Policy Changes

Non-preferred adalimumab products (Revised)

Humana has revised its prior authorization policy for non-preferred adalimumab products on Medicare Advantage plans. This is a 1-day-old policy update that requires billing teams to verify authorization status before claims submission for non-preferred adalimumab formulations. The specific clinical criteria and preferred product alternatives are not detailed in the summary-only source provided.